CatalystFDA/Bio

BELITE BIO OUTLINES FEBRUARY 12, 2027 PDUFA DATE FOR TINLAREBANT IN STARGARDT DISEASE FOLLOWING FDA PRIORITY REVIEW ACCEPTANCE - SEEKINGALPHA

PDUFA date and priority review signal regulatory catalyst for tinlarebant.

What changed

PDUFA date and priority review signal regulatory catalyst for tinlarebant.

Why it matters

PDUFA date and priority review signal regulatory catalyst for tinlarebant. — impact context not separately stored; see What changed.

Sources